Quoin Pharmaceuticals(QNRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QNRX Quoin Pharmaceuticals

Closed 10-06 16:00:00 EDT

4.72

+0.17

+3.62%

盘后4.72

+0.000.00%

18:51 EDT

High4.88	Low4.35	Vol103.83K
Open4.48	D1 Closing4.56	Amplitude11.64%
Mkt Cap22.68M	Tradable Cap21.84M	Total Shares4.80M
T/O476.10K	T/O Rate2.24%	Tradable Shares4.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":4.72,"timestamp":1791316800000,"preClose":4.555,"halted":0,"volume":103829,"hourTrading":{"tag":"盘后","latestPrice":4.72,"preClose":4.72,"latestTime":"18:51 EDT","volume":4550,"amount":22048.8537,"timestamp":1791327067437,"change":0,"changeRate":0,"amplitude":0.222458},"delay":0,"changeRate":0.0362239297475302,"floatShares":4628002,"shares":4804200,"eps":-8.521029,"marketStatus":"Closed","change":0.165,"latestTime":"10-06 16:00:00 EDT","open":4.48,"high":4.88,"low":4.35,"amount":476099.5420313,"amplitude":0.116356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.521029,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791360000000},"marketStatusCode":5,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":4.555,"preHourTrading":{"tag":"盘前","latestPrice":4.59,"preClose":4.555,"latestTime":"07:25 EDT","volume":960,"amount":4170.449952,"timestamp":1791285904280,"change":0.035,"changeRate":0.007684,"amplitude":0.094402},"postHourTrading":{"tag":"盘后","latestPrice":4.72,"preClose":4.72,"latestTime":"18:51 EDT","volume":4550,"amount":22048.8537,"timestamp":1791327067437,"change":0,"changeRate":0,"amplitude":0.222458},"volumeRatio":1.938034},"requestUrl":"/m/hq/s/QNRX","defaultTab":"news","newsList":[{"id":"2673305878","title":"Quoin Says Qrx003 Pediatric Compassionate-Use Case Report Accepted for Publication in Dermatology and Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673305878","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673305878?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:30","pubTimestamp":1791282634,"startTime":"0","endTime":"0","summary":"Quoin says QRX003 pediatric compassionate-use case report accepted for publication in Dermatology and TherapyQuoin Pharmaceuticals announced acceptance of a peer-reviewed paper on QRX003 for Netherton","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL6MHqkc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","BK4585","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","NDAQ","QNRX","BK4588","IE00BKPKM429.USD","BCDF","SG9999014005.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","LU2210150020.SGD","BK4112","LU0314104364.USD","SG9999014021.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484141","title":"Quoin Pharmaceuticals Price Target Announced at $20.00/Share by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669484141?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:32","pubTimestamp":1790173920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QNRX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144430","title":"Quoin Pharma Wins FDA Fast Track Status for Qrx003 in Peeling Skin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144430","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144430?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:33","pubTimestamp":1790080412,"startTime":"0","endTime":"0","summary":"Quoin Pharma wins FDA fast track status for QRX003 in peeling skin syndromeFDA granted Fast Track designation to Quoin’s QRX003 for Peeling Skin Syndrome, a rare genetic skin disease with no approved ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL2zjv71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","BK4139","IE00BQXX3C00.GBP","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","BCDF","NDAQ","QNRX","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BQXX3F31.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668797598","title":"Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2668797598","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668797598?lang=en_us&edition=fundamental","pubTime":"2026-09-19 05:05","pubTimestamp":1789765509,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 9.37M American depositary shares. The company is n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-registers-to-sell-9-37m-adrs-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-registers-to-sell-9-37m-adrs-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139","SCHY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666852516","title":"Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666852516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666852516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:33","pubTimestamp":1789072437,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has issued an update. On September 8, 2026, Quoin Pharmaceuticals reported that the U.S. Food and Drug Administra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","QNRX","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959327","title":"Quoin Evaluates Qrx003 in Phase 2/3 Trial for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666959327?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:30","pubTimestamp":1789043428,"startTime":"0","endTime":"0","summary":"Quoin evaluates QRX003 in Phase 2/3 trial for Netherton syndromeQuoin Pharmaceuticals highlighted positive interim results already released on Aug. 28 from its ongoing Phase 2/3 QRX003 trial in Nether","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9n9lk9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","QNRX","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","BK4139","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595833","title":"Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595833","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595833?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:30","pubTimestamp":1789043400,"startTime":"0","endTime":"0","summary":"This New Video Explores the Daily Realities of Raising a Child with Netherton Syndrome, and Its Impact on the Whole FamilyASHBURN, Va., Sept.  10, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359506/0/en/quoin-pharmaceuticals-releases-new-netherton-now-video-aminah-s-story-featuring-laura-wright-sexton-md-the-physician-who-first-met-her-daughter-in-the-icu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665537583","title":"Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003","url":"https://stock-news.laohu8.com/highlight/detail?id=2665537583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665537583?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:05","pubTimestamp":1788872727,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that the FDA has granted Rare Pediatric Disease Designation for the company’s lead asset, QRX003, for the tr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-granted-rare-pediatric-disease-designation-for-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-granted-rare-pediatric-disease-designation-for-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665789303","title":"Quoin Says FDA Grants Rare Pediatric Disease Designation for Qrx003 in Peeling Skin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2665789303","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665789303?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:34","pubTimestamp":1788870852,"startTime":"0","endTime":"0","summary":"Quoin says FDA grants rare pediatric disease designation for QRX003 in peeling skin syndromeFDA granted Rare Pediatric Disease designation for QRX003 in Peeling Skin Syndrome, extending a prior design","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3wnZkK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","BK4139","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","BK4588","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2095319765.USD","IE00B64PRP62.GBP","BK4585","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","SG9999014039.USD","BCDF","LU0314104364.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","QNRX","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664806777","title":"Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664806777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664806777?lang=en_us&edition=fundamental","pubTime":"2026-09-04 02:30","pubTimestamp":1788460208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dogwood Therapeutics (DWTX) and Quoin Pharmaceutical...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dogwood-therapeutics-dwtx-quoin-pharmaceuticals-qnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dogwood-therapeutics-dwtx-quoin-pharmaceuticals-qnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XLV","HCSG","BK4581","XBI","LABU","BK4137","BK4588","BK4139","QNRX","DWTX","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664952860","title":"Quoin Pharmaceuticals Director Anthony James Culverwell Acquires Shares Worth $29,988.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2664952860","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664952860?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:38","pubTimestamp":1788313136,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals director Anthony James Culverwell acquires shares worth $29,988.48Quoin Pharmaceuticals director Anthony James Culverwell bought 6,146 ADSs at USD 4.88 in a private placement.Hol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbmH65M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Quoin Pharmaceuticals Director Anthony James Culverwell Acquires Shares Worth $29,988.48","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677510","title":"U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677510","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677510?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:41","pubTimestamp":1787917296,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta BeautyAugust 28 (Reuters)-Futures tied to the S&P 500 and Nasdaq inched lower on Friday after Nvidia's stellar forecast sparked a technology ra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","SG9999014914.USD","LU1400636574.HKD","LU0157215616.USD","SOXX","LU2279689827.SGD","WGMI","ESLG","BK4503","LU0444971666.USD","ABFL","LU0203202063.USD","SG9999018857.SGD","FINX","LU0528227936.USD","MRNX","LU1244550494.USD","LU0868494617.USD","LU0882574139.USD","LU1069344957.HKD","LU2294711713.HKD","LU2430703251.USD","LU0444973449.USD","BK4227","LU2360107168.USD","LU0965509010.AUD","XLK","BK4550","IE0034235295.USD","LU0154236417.USD","LU2237957902.USD","LU2023250330.USD","NVDA","LU0965509101.SGD","LU0417517546.SGD","SG9999015358.SGD","IREX","LU1202635105.USD","LU0823421333.USD","BK4527","IE0004091025.USD","LU1868837136.USD","IE0009G5SDU7.USD","LU2092937148.SGD","LU1116320901.HKD","LU0868494708.USD","LU0289960550.SGD","LU0081259029.USD","LU0211327993.USD","LU2168564222.USD","LU2430703095.HKD","EFIV","SGXZ51526630.SGD","LU0215105999.USD","SG9999004303.SGD","BK4592","LU1983260115.SGD","LU0175139822.USD","LU0072462426.USD","LU1934455277.USD","SG9999018865.SGD","LU2417539215.USD","BK4539","MRNY","LU1914381329.SGD","LU0466842654.USD","LU2237957811.SGD","BK4085","SG9999015341.SGD","LU0985320562.USD","LU2077746001.SGD","LU3102509885.SGD","LU1861220207.SGD","LU0256863811.USD","SNPE","STBQ","LU2047632596.USD","LU2097344357.USD","LU1066051811.HKD","LU1839511570.USD","LU1923621640.USD","HK0000819398.USD","NVDD","LU0943347566.SGD","BK4097","IE00BZ1G4Q59.USD","SG9999014575.USD","LU0174119429.USD","LU0082616367.USD","ESUM","LU2125154778.USD","IE00BFSS8Q28.SGD","LU2238339852.HKD","IE000YTNTUN2.SGD","LU0251132253.USD","LU0642271901.SGD","LU0823411888.USD","LU2461242641.AUD","IE000Q6AESB8.SGD","LU1043141123.HKD","LU2097344431.USD","LU2347655073.USD","LU0795875169.SGD","LU1989764748.USD","LU0128525929.USD","LU2552382215.SGD","LU1169590202.USD","LU2361045086.USD","LU2433249047.HKD","PYPY","TTWO","SNVD.UK","LU0889565833.HKD","IE00BQXX3C00.GBP","IE0004086264.USD","LU1116320737.USD","IE00BWXC8680.SGD","NERD","LU1880398554.USD","IREC","LU0069063385.USD","BK4587","BK4534","LU1935043536.SGD","IE0004445239.USD","LU0557290698.USD","LU2471134879.HKD","LU2452424414.USD","LU2471134952.CNY","BK4535","LU2092627202.USD","2NVD.UK","IE00BMPRXN33.USD","IE0003U64NQ7.SGD","LU1917777945.USD","LU1815333072.USD","LU0077335932.USD","CYTK","LU2249611893.SGD","LU0979878070.USD","LU2125154935.USD","LU0820562030.AUD","LU1119994496.HKD","LU0211328371.USD","LU0689626769.HKD","LU2750360641.GBP","FTEC","SHOC","LU2168564495.EUR","HK0000914686.HKD","LU0661504455.SGD","SG9999017495.SGD","LTL","LU1035775433.USD","LATR","IETC","LU2322448957.HKD","LU2237443978.SGD","IE00B19Z9P08.USD","LU0289961442.SGD","LU0787776722.HKD","LU2168564065.EUR","NVC","IE00B19Z8X17.USD","TTEQ","LU1551013425.SGD","IE000KEQY171.SGD","FDIG","LU1778281490.HKD","LU1852331112.SGD","LU1934455194.USD","NVDW","GAMR","07788","LU2106854487.HKD","IE00BK4W5L77.USD","LU1571399168.USD","LU1670756490.USD","LU1429558221.USD","HK0000306701.USD","LU2083900584.USD","ESPO","LU1267930730.SGD","LU1989764664.SGD","CNEQ","IE00B4YYXB79.USD","BK4612","LU1127390331.HKD","LU0823414551.USD","LU1064131342.USD","LU0210533765.USD","LU2168563687.JPY","LU0048584097.USD","LU2237443465.HKD","LU2242649171.HKD","TYLG","LU0345769631.USD","IE00B1XK9C88.USD","LU1066051498.USD","LU2462591350.SGD","BK4614","LU1791710400.SGD","LU2420271590.USD","BK4528","LU2463028550.USD","LU1066053197.SGD","LU0719512351.SGD","LU1814569148.SGD","CLSE","IE00B894F039.SGD","ROM","BK4554","USD","NVII","LU0345770308.USD","LU0011850046.USD","LU1316542783.SGD","LU0689472784.USD","LU2413666426.HKD","IE00B7KXQ091.USD","CHPX","SG9999015986.USD","LU1732800096.USD","SG9999014559.SGD","LU1791807156.HKD","LU0225283273.USD","LU0823434740.USD","IE00B19Z9505.USD","LU0187121727.USD","LU0124676726.USD","SGXZ31699556.SGD","LU1674673428.USD","LU0708995401.HKD","LU1496350502.SGD","LU0256863902.USD","LU2125909759.SGD","NVD3.UK","LU0143551892.USD","LU0964807845.USD","LU0823434583.USD","LU1720051108.HKD","LU1235294995.USD","LU2065170008.USD","VGT","BK4533","SG9999014906.USD","LU0354030438.USD","IE0034235303.USD","LU1323610961.USD","SGXZ99366536.SGD","LU0057025933.USD","LU1880398471.USD","LU2462591277.SGD","LU2125910179.SGD","GAP","LU1923623000.USD","LU1988902786.USD","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU1069347547.HKD","LU2054465674.USD","IE00B1BXHZ80.USD","LU0823421416.USD","IREG","LU2462157665.USD","NVD","LU2237443622.USD","ADSK","LU2211815571.USD","LU1623119135.USD","CMAG","HK0000306685.HKD","LU2592432038.USD","LU2148611432.USD","LU0353189763.USD","LU1633808545.USD","LU1144417596.USD","LU1979441026.SGD","LU2456880835.USD","LU2360106780.USD","SG9999014898.SGD","LU1674673691.USD","LU0109392836.USD","ARTY","IE00B775H168.HKD","BK4524","GNOM","IXN","LU1823568750.SGD","BK4094","BK4566","NVDS.UK","GB00BDT5M118.USD","LU0006306889.USD","IE00BJJMRX11.SGD","IE0001KFT4U8.USD","LU0323591593.USD","LU1003077747.HKD","LU2272731865.HKD","IE000ITXATA3.USD","BK4501","LU0320765059.SGD","BK4543","LU2357305700.SGD","LU0683600562.USD","SG9999015978.USD","LU1551013342.USD","SG9999001424.SGD","LU2458330243.SGD","AFRU","BK4551","IE00BJLML261.HKD","LU0170899867.USD","BK4516","LU0820561818.USD","IE00BKDWB100.SGD","LU0234572021.USD","SG9999014880.SGD","LU0788109477.HKD","LU0353189680.USD","LU2347655156.SGD","LU2360032135.SGD","LU2750360997.AUD","IE00B4JS1V06.HKD","SOXY","LU1366333091.USD","SG9999000418.SGD","LU2505996509.AUD","S","LU0390134368.USD","LU0994945656.USD","HK0000532082.HKD","LU0949170772.SGD","LU2552382058.USD","LU0234570918.USD","BK4581","LU0426417589.USD","LU0127658192.USD","LU2505996681.GBP","LU1989772840.SGD","PYPU","LU1668664300.SGD","LU0106831901.USD","ULTA","LU2271345857.HKD","IE00B775SV38.USD","LU0957808578.USD","LU0708994859.HKD","LU1232071149.USD","BK4579","LU2100268510.USD","RSPC","NVD2.UK","BK4549","LU2168564149.EUR","LU1951198990.SGD","IE00BYXW3230.USD","LU0342679015.USD","NULC","NVDO","SG9999002224.SGD","LU0347712357.USD","LU0061474705.USD","LU1868836914.USD","LU1868836757.USD","IE0034235188.USD","LU2756315664.SGD","NVYY","IE00BDCRKT87.USD","PYPL","LU1153585028.USD","TTXU","LU2403377893.USD","LU1712237335.SGD","NVDX","LU1169589451.USD","IE00B5949003.HKD","BK4561","BK4548","LU0511384066.AUD","WISE","SG9999014542.SGD","LU1496350171.SGD","LU0345770993.USD","NVIW.SI","SGXZ81514606.USD","LU2065171402.SGD","LU1548497426.USD","BK4560","LU1821325948.USD","IE0009356076.USD","LU1691799644.USD","BK4600","LU2023250504.SGD","HK0000320223.HKD","LU0672654240.SGD","SG9999015945.SGD","LU0267386448.USD","LU2089283258.USD","IE0005OL40V9.USD","LU2125909916.SGD","LU1951200564.SGD","METV","LU2999663052.SGD","LU1244550221.USD","LU2125909593.SGD","NVDQ","IE00BJJMRY28.SGD","BK4200","LU2491050071.SGD","LU1935043023.USD","WDNA","LU1861220033.SGD","SPTE","LU0472753341.HKD","LU1037948541.HKD","LU0726765562.USD","LU0070217475.USD","LU1121112475.USD","LU0345774631.USD","PYPG","LU0289739343.SGD","SGXZ80539844.SGD","LU1939255532.USD","NVDB","LU0210536198.USD","HK0000320264.USD","BITQ","LU0395794307.EUR","BK4141","LU2065171311.SGD","LGHT","LU2286300806.USD","LU0323240290.USD","LU1242518857.USD","LU0494093205.USD","SG9999014567.USD","IE00B19Z9Z06.USD","LU2089284900.SGD","SG9999015952.SGD","LU2242650005.HKD","IREN","LU0096364046.USD","LU0965508806.USD","LU0942090050.USD","LU1035773651.USD","LU0316494557.USD","TEK","LU1699723380.USD","LU2298064838.USD","LU0345768740.USD","IBLC","LU1815336760.USD","BK4139","LU2896262040.SGD","JGRO","LU0097036916.USD","LU1934455863.HKD","LU2458330169.SGD","LU2506951792.HKD","LU2125910336.SGD","LU0210528500.USD","LU0096362180.USD","LU0310800379.SGD","FAI","LU1803068623.USD","LU2087621335.USD","LU1803068979.SGD","LU0056508442.USD","LU1261432733.SGD","SOXQ","BK4109","LU2272731600.USD","LU2237443895.HKD","IE00BQXX3D17.EUR","LFGY","LU1037948897.HKD","AIPI","LU1642822529.SGD","LU2087625088.SGD","LU2394011477.USD","TRFK","LU1267930573.SGD","LU2471134796.USD","LU1935042488.USD","BK4567","BK4605","LU0345774391.USD","BK4505","ILDR","LU2756315318.SGD","IE00B3SWFQ91.USD","NVDU","LU0053666078.USD","HK0000914660.USD","LU2237443382.USD","LU2471134523.USD","LU0308772762.SGD","IE00BZ9MQY76.HKD","LU1720051017.SGD","LU1242518931.SGD","LU2361044949.HKD","ANV","LU2133065610.SGD","SGXZ23171101.USD","IE000W1ABFV2.USD","DIPS","LU1935042215.USD","LU2213496289.HKD","NVDS","LU2125909247.SGD","SOLS","LU2430703178.SGD","DAPP","LU0080751232.USD","BKCH","LU0274383776.USD","BK4595","AGOX","LU0553294199.USD","LU2065169927.USD","LU0861579265.USD","LU0238689110.USD","LU2272731782.SGD","LU1046421795.USD","IREZ","LU2108987350.USD","IE00BN29S564.USD","LU2063271972.USD","LU2543165471.USD","LU0354030511.USD","LU1992135399.USD","LU0640476718.USD","BTAI","BK4529","NVDL","SMH","LU0061475181.USD","LU2265009873.SGD","LU2191332357.HKD","IE00B5TLWC47.USD","LU1923622614.USD","LU1923622291.USD","BK4106","LU2290526834.HKD","XLC","LU2237438978.USD","BK4598","IE00B3S45H60.SGD","LU0265550359.USD","LU1861217088.USD","LU0476273544.USD","LU0786609619.USD","LU0061474960.USD","LU1244550577.SGD","IE00B3M56506.USD","LU2552382132.HKD","IE00BJTD4N35.SGD","IE0004445015.USD","LU1435385759.SGD","LU2860962120.EUR","LU2491050154.USD","IE00BKVL7J92.USD","BK4532","LU2637965513.SGD","BK4023","IE00BHPRN162.USD","AIFD","BNGE","LU0265550946.USD","LU1084165304.USD","SG9999002232.USD","BK4568","LU2111349929.HKD","IE00BFSS7M15.SGD","LU1718418525.SGD","3NVD.UK","HK0000304805.HKD","LU1280957306.USD","IE00BD6J9T35.USD","LU1935042991.SGD","LU2602419157.SGD","LU1861215975.USD","LU2746668461.USD","07388","LU2381873111.SGD","LU0545039389.USD","LU2023251221.USD","IE00BMPRXR70.SGD","QNRX","LU0310799852.SGD","LU0348723411.USD","IE00BQXX3F31.USD","BK4588","LU2028103732.USD","LU2357125470.USD","LU2360107671.USD","THMR","LU0823414478.USD","LU2244417387.USD","LU0158827948.USD","HK0000304797.USD","IE00B19Z8W00.USD","LU0094547139.USD","LU0107464264.USD","LU2326559502.SGD","LU2954938101.SGD","LU2473716301.USD","LU2361044865.SGD","VT","LU0965509283.SGD","LU0133085943.USD","LU1400636491.USD","LU1043141396.HKD","LU1992135472.HKD","LU1721428933.USD","HERO","IPAY","LU1267930490.SGD","LU2931357623.SGD","IE00BDRTCR15.USD","IE00BJTD4V19.USD","LU0323239441.USD","CHAT","LU1400636657.SGD","IE00BZ199S13.USD","USXF","IE00BKPKM429.USD","LU1791710582.SGD","LU2250418816.HKD","SMHX","LU0029864427.USD","LU0738911758.USD","LU0266013472.USD","SNVDAmain","LU1645745479.HKD","LU1989772923.USD","LU2237443549.SGD","LU2322448791.USD","LU0079474960.USD","LU1974910355.USD","LU0724617625.USD","AFRM","LU0795875086.SGD","LU2247934214.USD","LU2491049909.HKD","STCE","NVDY","LU2089985449.USD","LU1868836591.USD","LU2264538146.SGD","MRNA","FDTX","IE00BK4W5M84.HKD","LU0106261372.USD","LU0109391861.USD","LU0138981039.USD","BK4585","BK4608","LU0158827781.USD","LU1629891620.HKD","LU0276348264.USD","LU1732799900.SGD","LU2746668974.SGD","LU0912757837.SGD","LU2236285917.USD","NVDG","IDNA","LU0820561909.HKD","IRE","LU1804176565.USD","LU1145028129.USD","LU2487616109.SGD","LU1066051225.USD","LU0957791311.USD","IE00BMPRXQ63.HKD","LU0426412945.USD","MNRS","LU2413666699.HKD","LU1861127337.USD","LU0345768153.USD","LU0345769128.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069389","title":"Quoin Reports Positive Interim Phase 2/3 Data for Qrx003 in Netherton Syndrome Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069389","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662069389?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:00","pubTimestamp":1787911244,"startTime":"0","endTime":"0","summary":"Quoin reports positive interim Phase 2/3 data for QRX003 in Netherton syndrome trialQuoin Pharmaceuticals posted interim Phase 2/3 results for QRX003 lotion in Netherton syndrome, based on the first s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLbTfcmz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4139","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","QNRX","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069800","title":"Quoin Pharma Prices Unregistered $50 Million Private Placement at $4.88 Per ADS","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069800","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662069800?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:00","pubTimestamp":1787911230,"startTime":"0","endTime":"0","summary":"Quoin Pharma prices unregistered $50 million private placement at $4.88 per ADSQuoin Pharmaceuticals priced a private placement to raise up to USD 50 million, including USD 30.8 million upfront.Sale c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1mzqZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","BK4112","BK4139","IE00B64PRP62.GBP","IE00BN0W2W23.USD","QNRX","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3F31.USD","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662406957","title":"Press Release: Quoin Pharmaceuticals Announces Private Placement Financing of up to $50.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662406957","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662406957?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:00","pubTimestamp":1787911200,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Quoin Pharmaceuticals Announces Private Placement Financing of up to $50.0 Million","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923744","title":"Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923744","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923744?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:07","pubTimestamp":1787260050,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has provided an announcement. At its 2026 Annual General Meeting of Shareholders held on August 20, 2026, Quoin P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-shareholders-approve-governance-and-compensation-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-shareholders-approve-governance-and-compensation-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232562","title":"Quoin Pharmaceuticals Shareholders Approved 401(k) Matching Contribution Changes at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232562","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232562?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:19","pubTimestamp":1787257196,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals shareholders approved 401(k) matching contribution changes at annual meetingQuoin Pharmaceuticals held its annual general meeting on Aug. 20, 2026.Shareholders backed changes to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL9hSNtx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659836177","title":"Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659836177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659836177?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:18","pubTimestamp":1786886333,"startTime":"0","endTime":"0","summary":"“The second quarter was a highly productive period across both of our delivery technology platforms,” said Michael Myers, Chief Executive Officer a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q2-eps-1-90-consensus-1-77-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q2-eps-1-90-consensus-1-77-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140082","title":"Quoin Pharmaceuticals Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140082","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140082?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:23","pubTimestamp":1786721003,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings SummaryQuoin Pharmaceuticals LtdQNRX.OQreported a quarterly adjusted loss of $1.90 per share for the quarter ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B14B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659141881","title":"Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659141881","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659141881?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:33","pubTimestamp":1786710790,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.90) per share which missed the analyst consensus estimate of $(1.61) by 18.01 percent. This is a 69.75 percent increase over losses of $(6.28) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61206411/quoin-pharmaceuticals-q2-eps-1-90-misses-1-61-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quoinpharma.com","stockEarnings":[{"period":"1week","weight":-0.134},{"period":"1month","weight":-0.3726},{"period":"3month","weight":-0.051},{"period":"6month","weight":-0.2396},{"period":"1year","weight":-0.3674},{"period":"ytd","weight":-0.6843}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.006},{"period":"3month","weight":0.0363},{"period":"6month","weight":0.1462},{"period":"1year","weight":0.1578},{"period":"ytd","weight":0.1362}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.264124},{"month":2,"riseRate":0.2,"avgChangeRate":-0.199382},{"month":3,"riseRate":0.2,"avgChangeRate":-0.222445},{"month":4,"riseRate":0.2,"avgChangeRate":-0.15112},{"month":5,"riseRate":0.4,"avgChangeRate":-0.043514},{"month":6,"riseRate":0.4,"avgChangeRate":-0.066019},{"month":7,"riseRate":0.4,"avgChangeRate":-0.043305},{"month":8,"riseRate":0.6,"avgChangeRate":0.001072},{"month":9,"riseRate":0,"avgChangeRate":-0.220179},{"month":10,"riseRate":0.4,"avgChangeRate":0.179253},{"month":11,"riseRate":0.4,"avgChangeRate":0.035616},{"month":12,"riseRate":0.2,"avgChangeRate":-0.187047}],"exchange":"NASDAQ","name":"Quoin Pharmaceuticals","nameEN":"Quoin Pharmaceuticals","securityTypeName":"DR","adrRate":"1:35"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Quoin Pharmaceuticals(QNRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Quoin Pharmaceuticals(QNRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Quoin Pharmaceuticals,QNRX,Quoin Pharmaceuticals股票,Quoin Pharmaceuticals股票老虎,Quoin Pharmaceuticals股票老虎国际,Quoin Pharmaceuticals行情,Quoin Pharmaceuticals股票行情,Quoin Pharmaceuticals股价,Quoin Pharmaceuticals股市,Quoin Pharmaceuticals股票价格,Quoin Pharmaceuticals股票交易,Quoin Pharmaceuticals股票购买,Quoin Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quoin Pharmaceuticals(QNRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Quoin Pharmaceuticals(QNRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction